Concord Neonatal, one of the ventures in NLC portfolio, has closed a new funding round, securing substantial funding with private investors. Concord Neonatal is improving birth, by offering solutions to give baby’s a shock-free birth. This new funding allows the company to expand sales internationally and continue to scale-up.
Recent news
NLC successfully closes €20 million equity financing round to further strengthen and scale its venture building model
Amsterdam, Friday 23 April 2021 – NLC is proud to announce that its latest funding round is successfully closed. Investments come from family offices…
Read more
Aetherus
News: Aetherus signed a contract with an American partner that will be responsible for FDA approval and marketing & sales in North America. The…
Read more
OsteoWeld received grant from Innovate UK
News: OsteoWeld received a GBP500k grant from Innovate UK. The submission was prepared together with the University of Birmingham, which will collaborate with OsteoWeld…
Read more